[1] JEFFS L, JAIN AK, MAN HT, et al. Exploring the utility and scalability of a telehomecare intervention for patients with chronic kidney disease undergoing peritoneal dialysis-a study protocol[J]. BMC Nephrol, 2017, 18(1): 155. doi: 10.1186/s12882-017-0557-y
[2] SIM JJ, ZHOU H, SHI J, et al. Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters[J]. Int Urol Nephrol, 2018, 50(2): 963.
[3] 刘华晔, 姚瑶, 曹艳佩, 等. 腹膜透析相关腹膜炎的病原菌耐药性分析[J]. 中华医院感染学杂志, 2017, 27(17): 3905.
[4] YOSHIHARA H, YONEOKA D. In-hospital outcomes of patients with advanced chronic kidney disease, dialysis, and kidney transplant undergoing spinal fusion: analysis of a nationwide database[J]. Clin Spine Surg, 2018, 31(9): 400. doi: 10.1097/BSD.0000000000000692
[5] JEAN G, SOUBERBIELLE JC, CHAZOT C. Vitamin D in chronic kidney disease and dialysis patients[J]. Nutrients, 2017, 9(4): 722.
[6] 中国腹膜透析置管专家组. 中国腹膜透析置管指南[J]. 中华肾脏病杂志, 2016, 32(11): 867. doi: 10.3760/cma.j.issn.1001-7097.2016.11.014
[7] KANG E, KIM S, LEE HJ, et al. Tumor necrosis factor α is a risk factor for infection in peritoneal dialysis patients[J]. Korean J Intern Med, 2016, 31(4): 722. doi: 10.3904/kjim.2015.230
[8] MULLEY WR, LE ST, IVES KE. Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: a systematic review and meta-analysis[J]. Nephrol Dial Transplant, 2017, 32(1): 136.
[9] 王坤, 任琳, 王金霞, 等. 腹膜透析发生肺部感染危险因素的病例对照研究[J]. 安徽医学, 2019, 40(8): 924. doi: 10.3969/j.issn.1000-0399.2019.08.023
[10] 陈伊文, 王月芳, 邓新, 等. 腹膜透析患者的远期预后及影响因素[J]. 肾脏病与透析肾移植杂志, 2019, 28(5): 412. doi: 10.3969/j.issn.1006-298X.2019.05.003
[11] 谢海萍, 赵芸, 余海峰, 等. 腹膜透析患者医院感染因素分析与对策[J]. 中华医院感染学杂志, 2016, 26(13): 3118.
[12] HU C, YANG M, ZHU X, et al. Effects of omega-3 fatty acids on markers of inflammation in patients with chronic kidney disease: a controversial issue[J]. Ther Apher Dial, 2018, 22(2): 124. doi: 10.1111/1744-9987.12611
[13] HU SL, JOSHI P, KAPLAN M, et al. Vitamin D and cinacalcet are associated with increased survival in peritoneal dialysis but not with residual renal function preservation[J]. Clin Nephrol, 2018, 90(5): 305. doi: 10.5414/CN109244
[14] KORATALA A, CHORNYY V, KAZORY A. Exit site infection in peritoneal dialysis; Need for follow-up on cultures despite clinical improvement[J]. Blood Purif, 2017, 44(1): 66. doi: 10.1159/000464348
[15] KHAN YH, SARRIFF A, ADNAN AS, et al. Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center[J]. Clin Exp Nephrol, 2017, 21(8): 1.
[16] 姚洁, 诸伟红, 葛玉英, 等. 慢性肾功能衰竭血液透析患者医院感染病原菌分布与临床特征分析[J]. 中华医院感染学杂志, 2015, 25(10): 2210.
[17] YILDIRIM U, GULEL O, EKSI A, et al. The effect of different treatment strategies on left ventricular myocardial deformation parameters in patients with chronic renal failure[J]. Int J Cardiovasc Imaging, 2018, 34(2): 1.
[18] ZHANG Q, WANG L, ZENG H, et al. Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study[J]. Bmc Nephrol, 2018, 19(1): 70. doi: 10.1186/s12882-018-0866-9